When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MDCO - The Medicines Company's inclisiran shows positive effect in HeFH study
The Medicines Company
Results from a Phase 3 clinical trial, ORION-9, evaluating the effect of The Medicines Company's (MDCO+2.3%) inclisiran on reducing "bad" cholesterol (LDL-C) in patients with familial hypercholesterolemia (FH), an inherited condition characterized by abnormally high levels of cholesterol in the blood, showed a treatment benefit. The data were presented at the American Heart Association Scientific Sessions in Philadelphia.
More news on: The Medicines Company, Alnylam Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,